Boldenone is a naturally occurring anabolic–androgenic steroid (AAS) and the 1(2)-dehydrogenated analogue of testosterone. Equipoise itself has never been marketed as a pharmaceutical drug. This drug is an anabolic androgenic steroid and synthetic derivative of testosterone that was originally developed for veterinary use but has since become one of the more common performance-enhancing drugs that athletes test positive for in sport.
Equipoise has a chemical structure that is very similar to testosterone, allowing it to help build proteins and increase the production of erythropoietin. Athletes sometimes use this compound, which may be sold on the black market, to increase muscle mass and strength. Athletes should be aware of the many health and safety issues surrounding Equipoise, in addition to its prohibition in sport.
Pharmacodynamics
Like other anabolic androgenic steroids (AAS), Equipoise acts as an agonist of the androgen receptor (AR). The activity of the “bold” is primarily anabolic and has low androgenic potency. “Bold” will increase nitrogen retention and protein synthesis, increase appetite, and stimulate the release of erythropoietin in the kidneys.
“Bold” is marketed as a veterinary drug under the name undecylenate and is sold under the following brand names: Boldebal H, Equipoise, and Sybolin. It is marketed as a veterinary combination drug with methandriol under the brand name Drive.
In Ukraine, it is marketed for human consumption as the injectable steroid Boldenol.
What is EQ used for?
There is no therapeutic or medical use for boldenone in humans. More specifically, it is not approved by the Food and Drug Administration (FDA) for use in humans for any reason.
In addition to being illegally sold and used for human performance enhancement, boldenone is used illicitly in racehorses to enhance performance, despite being banned for use in horses competing in Olympic and Paralympic events. On an international and agricultural level, boldenone is also largely illegal to use as a growth promoter for farm animals, and most countries have surveillance programs that test it on animals raised for food production.
What are the health risks of boldenone?
Boldenone causes decreased testosterone production in men. In animal studies, boldenone has led to significant harm to the reproductive system and fertility of males, including decreased size of the testes, lower sperm count, and lower sperm mobility. In addition, boldenone is classified as a probable human carcinogen by the International Agency for Research on Cancer.
